Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AbaStar MDx is a molecular diagnostics company specializing in the development of rapid, point-of-care (POC) testing solutions for infectious diseases. The company utilizes a proprietary isothermal nucleic acid amplification technology that enables high-sensitivity detection of pathogens without the need for complex laboratory equipment. Their primary focus has been on respiratory panels, including COVID-19 and Influenza A/B, designed for use in clinics, pharmacies, and other decentralized settings. By combining the accuracy of PCR with the speed and ease of rapid antigen tests, AbaStar MDx aims to improve patient outcomes through timely and accessible diagnostic information.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AbaStar MDx.